X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3747) 3747
Newsletter (65) 65
Book Chapter (18) 18
Newspaper Article (9) 9
Magazine Article (4) 4
Dissertation (2) 2
Government Document (1) 1
Publication (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3127) 3127
polycythemia-vera (2012) 2012
hematology (1937) 1937
mutation (1541) 1541
female (1494) 1494
male (1474) 1474
janus kinase 2 - genetics (1453) 1453
essential thrombocythemia (1384) 1384
middle aged (1249) 1249
aged (1080) 1080
adult (1017) 1017
polycythemia vera - genetics (1004) 1004
oncology (968) 968
myeloproliferative disorders - genetics (806) 806
polycythemia vera (797) 797
myelofibrosis (781) 781
tyrosine kinase jak2 (766) 766
myeloproliferative disorders (732) 732
myeloproliferative neoplasms (641) 641
polycythemia (612) 612
jak2 (600) 600
aged, 80 and over (592) 592
thrombocythemia, essential - genetics (542) 542
genetic aspects (513) 513
leukemia (504) 504
primary myelofibrosis - genetics (494) 494
animals (487) 487
primary myelofibrosis (399) 399
tumors (394) 394
diagnosis (393) 393
janus kinase 2 (366) 366
research (364) 364
hemic and lymphatic diseases (361) 361
risk factors (352) 352
polycythemia vera - pathology (335) 335
thrombosis (329) 329
prognosis (323) 323
adolescent (321) 321
mice (318) 318
polycythemia vera - diagnosis (314) 314
janus kinase 2 - metabolism (313) 313
disorders (296) 296
abridged index medicus (294) 294
analysis (294) 294
myeloid metaplasia (291) 291
cancer (267) 267
myeloproliferative disorders - pathology (265) 265
care and treatment (263) 263
myeloproliferative disorders - diagnosis (258) 258
polycythemia vera - complications (253) 253
expression (248) 248
young adult (246) 246
alleles (245) 245
signal transduction (244) 244
activating mutation (243) 243
polycythemia vera - drug therapy (235) 235
gene mutations (231) 231
amino acid substitution (230) 230
medicine & public health (230) 230
mutation, missense (229) 229
polycythemia vera - blood (216) 216
janus kinase 2 - antagonists & inhibitors (213) 213
jak2 v617f mutation (210) 210
pathology (210) 210
health aspects (209) 209
point mutation (207) 207
bone marrow (205) 205
hematology, oncology and palliative medicine (203) 203
acute myeloid-leukemia (202) 202
disease (202) 202
primary myelofibrosis - pathology (193) 193
phenotype (190) 190
thrombocythemia, essential - diagnosis (190) 190
v617f mutation (185) 185
receptors, thrombopoietin - genetics (183) 183
disease progression (181) 181
hydroxyurea (181) 181
bone marrow - pathology (180) 180
dna mutational analysis (180) 180
medicine, general & internal (180) 180
jak2v617f (178) 178
chronic myeloproliferative disorders (177) 177
stem cells (177) 177
cell biology (176) 176
neoplasms (174) 174
child (173) 173
international working group (172) 172
retrospective studies (172) 172
gene expression (171) 171
polymerase chain reaction (170) 170
thrombocythemia, essential - pathology (170) 170
chromosome aberrations (169) 169
proto-oncogene proteins - genetics (169) 169
treatment outcome (169) 169
mutation - genetics (167) 167
myeloproliferative disorders - drug therapy (167) 167
jak2 mutation (166) 166
primary myelofibrosis - diagnosis (166) 166
polycythemia - genetics (164) 164
erythropoietin (163) 163
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3714) 3714
German (32) 32
French (30) 30
Japanese (21) 21
Russian (20) 20
Chinese (15) 15
Portuguese (10) 10
Danish (6) 6
Italian (6) 6
Korean (6) 6
Spanish (6) 6
Czech (5) 5
Hungarian (5) 5
Ukrainian (3) 3
Dutch (2) 2
Norwegian (2) 2
Serbian (2) 2
Swedish (2) 2
Turkish (2) 2
Hebrew (1) 1
Indonesian (1) 1
Romanian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The New England journal of medicine, ISSN 1533-4406, 2015, Volume 372, Issue 7, pp. 601 - 612
Journal Article
Journal Article
Journal Article
Journal Article
Blood, ISSN 1528-0020, 2017, Volume 129, Issue 6, pp. 667 - 679
The genetic landscape of classical myeloproliferative neoplasm (MPN) is in large part elucidated... 
POLYCYTHEMIA-VERA | LEUKEMIC TRANSFORMATION | ACTIVATING MUTATION | CLONAL HEMATOPOIESIS | MUTANT CALRETICULIN | ACQUIRED UNIPARENTAL DISOMY | ESSENTIAL THROMBOCYTHEMIA | HEMATOLOGY | SOMATIC MUTATIONS | THROMBOPOIETIN RECEPTOR | HEMATOPOIETIC STEM | Thrombocythemia, Essential - physiopathology | Epigenesis, Genetic | Humans | Gene Expression Regulation, Neoplastic | STAT Transcription Factors - metabolism | Polycythemia Vera - genetics | Receptors, Granulocyte Colony-Stimulating Factor - genetics | Thrombocythemia, Essential - genetics | Calreticulin - genetics | Receptors, Erythropoietin - genetics | DNA (Cytosine-5-)-Methyltransferases - metabolism | DNA-Binding Proteins - metabolism | Polycythemia Vera - metabolism | Janus Kinase 2 - metabolism | Calreticulin - metabolism | Receptors, Granulocyte Colony-Stimulating Factor - metabolism | Polycythemia Vera - physiopathology | Primary Myelofibrosis - metabolism | Repressor Proteins - metabolism | Proto-Oncogene Proteins - metabolism | Enhancer of Zeste Homolog 2 Protein - genetics | Enhancer of Zeste Homolog 2 Protein - metabolism | Primary Myelofibrosis - physiopathology | Janus Kinase 2 - genetics | Repressor Proteins - genetics | Proto-Oncogene Proteins - genetics | DNA-Binding Proteins - genetics | Receptors, Thrombopoietin - metabolism | Disease Progression | DNA (Cytosine-5-)-Methyltransferases - genetics | Receptors, Thrombopoietin - genetics | Primary Myelofibrosis - genetics | STAT Transcription Factors - genetics | Mutation | Receptors, Erythropoietin - metabolism | Thrombocythemia, Essential - metabolism
Journal Article